Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Antifungal Activity of Plasmacytoid Dendritic Cells against Cryptococcus neoformans In Vitro Requires Expression of Dectin-3 (CLEC4D) and Reactive Oxygen Species.

Hole CR, Leopold Wager CM, Mendiola AS, Wozniak KL, Campuzano A, Lin X, Wormley FL Jr.

Infect Immun. 2016 Aug 19;84(9):2493-504. doi: 10.1128/IAI.00103-16. Print 2016 Sep.

2.

Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.

Nakamura Y, Sato K, Yamamoto H, Matsumura K, Matsumoto I, Nomura T, Miyasaka T, Ishii K, Kanno E, Tachi M, Yamasaki S, Saijo S, Iwakura Y, Kawakami K.

Infect Immun. 2015 Feb;83(2):671-81. doi: 10.1128/IAI.02835-14. Epub 2014 Nov 24.

3.

STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.

Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Mueller M, Wormley FL Jr.

Infect Immun. 2015 Dec;83(12):4513-27. doi: 10.1128/IAI.00935-15. Epub 2015 Sep 8.

4.

A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus.

Ramirez-Ortiz ZG, Lee CK, Wang JP, Boon L, Specht CA, Levitz SM.

Cell Host Microbe. 2011 May 19;9(5):415-24. doi: 10.1016/j.chom.2011.04.007.

5.

Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps.

Loures FV, Röhm M, Lee CK, Santos E, Wang JP, Specht CA, Calich VL, Urban CF, Levitz SM.

PLoS Pathog. 2015 Feb 6;11(2):e1004643. doi: 10.1371/journal.ppat.1004643. eCollection 2015 Feb.

6.

Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection.

Campuzano A, Castro-Lopez N, Wozniak KL, Leopold Wager CM, Wormley FL Jr.

PLoS One. 2017 Jan 20;12(1):e0169347. doi: 10.1371/journal.pone.0169347. eCollection 2017.

7.

The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans).

Ramirez-Ortiz ZG, Means TK.

Virulence. 2012 Nov 15;3(7):635-46. doi: 10.4161/viru.22295. Epub 2012 Oct 17. Review.

8.

Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL.

PLoS One. 2009 Sep 3;4(9):e6854. doi: 10.1371/journal.pone.0006854.

9.

Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.

Upadhya R, Lam WC, Maybruck B, Specht CA, Levitz SM, Lodge JK.

MBio. 2016 May 10;7(3). pii: e00547-16. doi: 10.1128/mBio.00547-16.

10.

Dectin-1 is not required for the host defense to Cryptococcus neoformans.

Nakamura K, Kinjo T, Saijo S, Miyazato A, Adachi Y, Ohno N, Fujita J, Kaku M, Iwakura Y, Kawakami K.

Microbiol Immunol. 2007;51(11):1115-9.

11.

Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus.

Gessner MA, Werner JL, Lilly LM, Nelson MP, Metz AE, Dunaway CW, Chan YR, Ouyang W, Brown GD, Weaver CT, Steele C.

Infect Immun. 2012 Jan;80(1):410-7. doi: 10.1128/IAI.05939-11. Epub 2011 Oct 28.

12.

Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects.

Almeida F, Wolf JM, da Silva TA, DeLeon-Rodriguez CM, Rezende CP, Pessoni AM, Fernandes FF, Silva-Rocha R, Martinez R, Rodrigues ML, Roque-Barreira MC, Casadevall A.

Nat Commun. 2017 Dec 6;8(1):1968. doi: 10.1038/s41467-017-02126-7.

13.

Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.

Hardison SE, Wozniak KL, Kolls JK, Wormley FL Jr.

Infect Immun. 2010 Dec;78(12):5341-51. doi: 10.1128/IAI.00845-10. Epub 2010 Oct 4.

14.

In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Wozniak KL, Vyas JM, Levitz SM.

Infect Immun. 2006 Jul;74(7):3817-24.

16.

Contribution of the myeloperoxidase-dependent oxidative system to host defence against Cryptococcus neoformans.

Aratani Y, Kura F, Watanabe H, Akagawa H, Takano Y, Ishida-Okawara A, Suzuki K, Maeda N, Koyama H.

J Med Microbiol. 2006 Sep;55(Pt 9):1291-9.

PMID:
16914663
17.

Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.

Wozniak KL, Hole CR, Yano J, Fidel PL Jr, Wormley FL Jr.

Microbiology. 2014 Jul;160(Pt 7):1440-52. doi: 10.1099/mic.0.073445-0. Epub 2014 Apr 23.

18.

IL-4 receptor-alpha-dependent control of Cryptococcus neoformans in the early phase of pulmonary infection.

Grahnert A, Richter T, Piehler D, Eschke M, Schulze B, Müller U, Protschka M, Köhler G, Sabat R, Brombacher F, Alber G.

PLoS One. 2014 Jan 27;9(1):e87341. doi: 10.1371/journal.pone.0087341. eCollection 2014.

19.

Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain.

Wormley FL Jr, Perfect JR, Steele C, Cox GM.

Infect Immun. 2007 Mar;75(3):1453-62. Epub 2007 Jan 8.

20.

Supplemental Content

Support Center